Literature DB >> 10747040

DNA polymerase mu (Pol mu), homologous to TdT, could act as a DNA mutator in eukaryotic cells.

O Domínguez1, J F Ruiz, T Laín de Lera, M García-Díaz, M A González, T Kirchhoff, C Martínez-A, A Bernad, L Blanco.   

Abstract

A novel DNA polymerase has been identified in human cells. Human DNA polymerase mu (Pol mu), consisting of 494 amino acids, has 41% identity to terminal deoxynucleotidyltransferase (TdT). Human Pol mu, overproduced in Escherichia coli in a soluble form and purified to homogeneity, displays intrinsic terminal deoxynucleotidyltransferase activity and a strong preference for activating Mn(2+) ions. Interestingly, unlike TdT, the catalytic efficiency of polymerization carried out by Pol mu was enhanced by the presence of a template strand. Using activating Mg(2+) ions, template-enhanced polymerization was also template-directed, leading to the preferred insertion of complementary nucleotides, although with low discrimination values. In the presence of Mn(2+) ions, template-enhanced polymerization produced a random insertion of nucleotides. Northern-blotting and in situ analysis showed a preferential expression of Pol mu mRNA in peripheral lymphoid tissues. Moreover, a large proportion of the human expressed sequence tags corresponding to Pol mu, present in the databases, derived from germinal center B cells. Therefore, Pol mu is a good candidate to be the mutator polymerase responsible for somatic hyper- mutation of immunoglobulin genes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747040      PMCID: PMC310241          DOI: 10.1093/emboj/19.7.1731

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  59 in total

Review 1.  Novel DNA polymerases offer clues to the molecular basis of mutagenesis.

Authors:  E C Friedberg; V L Gerlach
Journal:  Cell       Date:  1999-08-20       Impact factor: 41.582

2.  Probing immunoglobulin gene hypermutation with microsatellites suggests a nonreplicative short patch DNA synthesis process.

Authors:  B Bertocci; L Quint; F Delbos; C Garcia; C A Reynaud; J C Weill
Journal:  Immunity       Date:  1998-08       Impact factor: 31.745

3.  Is terminal deoxynucleotidyl transferase a somatic mutagen in lymphocytes?

Authors:  D Baltimore
Journal:  Nature       Date:  1974-03-29       Impact factor: 49.962

4.  Variability in the lambda light chain sequences of mouse antibody.

Authors:  M G Weigert; I M Cesari; S J Yonkovich; M Cohn
Journal:  Nature       Date:  1970-12-12       Impact factor: 49.962

5.  Metal-polynucleotide interactions. A comparison of carcinogenic and non-carcinogenic metals in vitro.

Authors:  M J Murray; C P Flessel
Journal:  Biochim Biophys Acta       Date:  1976-03-04

6.  Origin of antibody variation.

Authors:  S Brenner; C Milstein
Journal:  Nature       Date:  1966-07-16       Impact factor: 49.962

7.  Mutagenesis during in vitro DNA synthesis.

Authors:  L A Weymouth; L A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

8.  Molecular mechanisms of manganese mutagenesis.

Authors:  W S El-Deiry; K M Downey; A G So
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

9.  On the enzymatic basis for mutagenesis by manganese.

Authors:  M F Goodman; S Keener; S Guidotti; E W Branscomb
Journal:  J Biol Chem       Date:  1983-03-25       Impact factor: 5.157

10.  On the fidelity of DNA replication: manganese mutagenesis in vitro.

Authors:  R A Beckman; A S Mildvan; L A Loeb
Journal:  Biochemistry       Date:  1985-10-08       Impact factor: 3.162

View more
  98 in total

1.  The many faces of DNA polymerases: strategies for mutagenesis and for mutational avoidance.

Authors:  E C Friedberg; W J Feaver; V L Gerlach
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 2.  A new class of errant DNA polymerases provides candidates for somatic hypermutation.

Authors:  B Tippin; M F Goodman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

Review 3.  Hypermutation in bacteria and other cellular systems.

Authors:  B A Bridges
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

Review 4.  Transcription, beta-like DNA polymerases and hypermutation.

Authors:  C A Reynaud; S Frey; S Aoufouchi; A Faili; B Bertocci; A Dahan; E Flatter; F Delbos; S Storck; C Zober; J C Weill
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

Review 5.  Managing DNA polymerases: coordinating DNA replication, DNA repair, and DNA recombination.

Authors:  M D Sutton; G C Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

Review 6.  Somatic hypermutation in human B cell subsets.

Authors:  N S Longo; P E Lipsky
Journal:  Springer Semin Immunopathol       Date:  2001-12

7.  Expression of error-prone polymerases in BL2 cells activated for Ig somatic hypermutation.

Authors:  V Poltoratsky; C J Woo; B Tippin; A Martin; M F Goodman; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

8.  The translesion DNA polymerase zeta plays a major role in Ig and bcl-6 somatic hypermutation.

Authors:  H Zan; A Komori; Z Li; A Cerutti; A Schaffer; M F Flajnik; M Diaz; P Casali
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

9.  Two novel human and mouse DNA polymerases of the polX family.

Authors:  S Aoufouchi; E Flatter; A Dahan; A Faili; B Bertocci; S Storck; F Delbos; L Cocea; N Gupta; J C Weill; C A Reynaud
Journal:  Nucleic Acids Res       Date:  2000-09-15       Impact factor: 16.971

10.  Two X family DNA polymerases, lambda and mu, in meiotic tissues of the basidiomycete, Coprinus cinereus.

Authors:  Aiko Sakamoto; Kazuki Iwabata; Akiyo Koshiyama; Hiroko Sugawara; Takuro Yanai; Yoshihiro Kanai; Ryo Takeuchi; Yoko Daikuhara; Yoichi Takakusagi; Kengo Sakaguchi
Journal:  Chromosoma       Date:  2007-09-02       Impact factor: 4.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.